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Background: Tumor epidemiology is a significant part of CNS (central nervous system) tumor studies.
Reassessment of original sections can update our knowledge of tumor spectrum. Here, we discuss the features of
CNS tumor pathology in a single center.
Methods: A total of 34140 cases from 1950 to 2009 were collected; sections from 1990 to 2009 were reassessed
according to WHO 2007 classification, and cases from 1950 to 1989 were classified according to the previous
pathological diagnosis.
Results: Seven CNS tumor categories during 1990 to 2009 were as follow: neuroepithelial tissue (38.0%), tumors of
the meninges (36.5%), tumors of the sellar region (4.1%), germ cell tumors (1.3%), tumors of cranial and paraspinal
nerves (13.3%), lymphomas and hematopoietic neoplasm (1.7%), metastatic tumors (5.1%), where histological types
by age and sex were diverse. Overall, males exceeded females in distributions of most CNS tumor subtypes, while
tumors of the meninges occurred more frequently in females. The case number of lymphomas and hematopoietic
neoplasms grew the fastest during the past five years, and the distribution of neuroepithelial tumors remained
stable over the past twenty years.
Conclusions: Despite the possibilities of cross sample biases, the data in this series could suggest a similar CNS
tumor spectrum as might occur in other developing countries.
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Central nervous system (CNS) tumors are not as frequent
as tumors of many other sites, such as those of the repara-
tive or digestive systems [1], but their incidence rate has in-
creased over time. A report from the International Agency
for Research on Cancer (IARC) revealed that the worldwide
incidence rate of CNS tumors in 2002, which was age-
adjusted and considered the standard world population,
was 3.7/100,000 persons among males and 2.6/100,000 per-
sons among females. The incidence rates were higher in de-
veloped countries (males: 5.8/100,000 persons; females: 4.1/
100,000 persons) than in less developed countries (males:
3.0/100,000 persons; females: 2.1/100,000 persons) [2]. In
2008, the rates had risen to 3.8/100,000 persons in males* Correspondence: lfzhouc@126.com
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reproduction in any medium, provided the orand 3.1/100,000 persons in females, although the incidence
rates in developed countries (males: 5.8/100,000 persons;
females: 4.4/100,000 persons) still remained higher than
those in less developed countries (males: 3.2/100,000 per-
sons; females: 2.8/100,000 persons). An overall increase has
been observed throughout the world, especially in less de-
veloped countries, which has captured our attention.
The Neurosurgical Department in Huashan Hospital is a
main clinical center for neurological diseases in China. In
this study, we retrospectively retrieved the neuropatho-
logical data obtained from our hospital during the period of
1950-2009 and analyzed the spatiotemporal changes rela-
tive to the published data over the past six decades from
other countries.Methods
This study was performed at the Neurosurgical Department
of the Huashan Hospital, Fudan University. Ethical approvaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Histological features of 27802 cases from 1990 to 2009
N (%) M F Ma(yrs) Ma(yrs)
I. Tumors of neuroepithelial tissue
1. Astrocytic tumors
Pilocytic astrocytoma 469 (1.69) 253 214 21.1 17
Pilomyxoid astrocytoma 20 (0.07) 8 12 19.2 17
Subependymal giant cell astrocytoma 27 (0.10) 15 12 16.2 13
Pleomorphic xanthoastrocytoma 67 (0.24) 33 34 28.4 23
Glioblastoma 2170 (7.81) 1362 805 50.2 53
Giant cell glioblastoma 12 (0.04) 9 3 42.7 41
Gliosarcoma 64 (0.23) 39 25 48.8 50.5
Anaplastic astrocytoma 939 (3.38) 593 346 49.2 42
Gliomatosis cerebri 3 (0.01) 2 1 59 62
2. Oligodendroglial tumors
Oligodendroglioma 990 (3.56) 555 426 38.6 39
Anaplastic oligodendrogliom 534 (1.92) 313 221 43.5 44
3. Oligoastrocytic tumors
Oligoastrocytoma 243 (0.87) 143 100 38.9 39
Anaplastic oligoastrocytoma 89 (0.32) 56 33 44.7 46
4. Ependymal tumors
Ependymoma 623 (2.24) 350 273 37 38
Subependymoma 39 (0.14) 21 18 43 43
Anaplastic ependymoma 223 (0.80) 129 93 30 30
5. Choroid plexus tumor
Choroid plexus papilloma 91 (0.33) 34 57 29 29
Atypical choroid plexus papilloma 2 (0.01) 0 2 37.5 37.5
Choroid plexus carcinoma 11 (0.04) 8 3 31.6 25
6. Other neuroepithelial tumors
Chordoid glioma of the third ventricle 3 (0.01) 1 2 31.3 27
Astroblastoma 4 (0.01) 2 2 37.8 42
7. Neuronal and mixed neuronal-glial tumors
Cerebellar liponeurocytoma 1 (0.00) 1 0 59 59
Desmoplastic infantile astrocytoma/ganglioglioma 5 (0.02) 1 4 16.8 11
Dysembryoplastic neuroepithelial tumor 54 (0.19) 34 20 22.6 17.5
Dysplastic gangliocytoma of cerebellum, Lhermitte-Duclos 7 (0.03) 3 4 28.7 38
Rosette-forming glioneuronal tumor of the fourth ventricle 4 (0.01) 0 4 28.3 24
Paraganglioma 29 (0.10) 14 15 42.5 42
Papillary glioneuronal tumor 13 (0.05) 9 4 32.4 29
Anaplastic ganglioglioma 43 (0.15) 26 17 39.7 41
Gangliocytoma 40 (0.14) 29 11 29.6 31.5
Ganglioglioma 137 (0.49) 87 49 33.1 32
Central neurocytoma 131 (0.47) 63 68 30.2 29
8. Tumors of pineal region
Papillary tumor of the pineal region 2 (0.01) 1 1 31.5 31.5
Pineocytoma 15 (0.05) 5 10 30.3 22
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Table 1 Histological features of 27802 cases from 1990 to 2009 (Continued)
Pineal parenchymal tumor of intermediate differentiation 5 (0.02) 5 0 26.8 20
Pineoblastoma 10 (0.04) 5 5 25.6 17.5
9. Embryonal tumors
Medulloblastoma 515 (1.85) 329 183 15.4 12
PNET 119 (0.43) 75 43 21.9 17
Atypical teratoid/rhabdoid tumor 4 (0.01) 2 2 21.8 23
II. Tumors of cranial and paraspinal nerves
1. Schwannoma (neurilemoma, neurinoma) 3499 (12.59) 1754 1736 45 45
2. Neurofibroma 166 (0.60) 106 60 36.3 38
3. Perineurioma 1 (0.00) 0 1 69 69
4. MPNST 26 (0.09) 11 15 37.8 42
III. Tumors of meninges
1. Tumors of meningothelial cells
Grade I meningothelial cells tumors 7623 (27.42) 2294 5309 50.7 51
Atypical 359 (1.29) 184 173 51.2 52
Chordoid 16 (0.06) 8 8 48.5 51
Clear cell 30 (0.11) 13 17 37.5 39.5
Papillary 26 (0.09) 16 10 36.7 35.5
Rhabdoid 15 (0.05) 9 6 42.2 42
Anaplastic, malignant 235 (0.85) 129 105 50.3 50
2. Mesenchymal tumors
Hemangiopericytoma 202 (0.73) 112 88 43.3 42
Anaplstic hemangiopericytoma 8 (0.03) 5 3 48.3 45.5
Other Mesenchymal tumors 825 (2.97) 450 369 36 37
3. Primarymelanocytic lesions
Diffuse melanocytosis 2 (0.01) 1 1 35.5 35.5
Melanocytoma 9 (0.03) 5 4 47 47
Malignantmelanoma 31 (0.11) 21 10 42.2 42
4. Other neoplasms related to the meninges
Hemangioblastoma 760 (2.73) 463 293 40.8 40
IV. Lymphomas and hematopoietic neoplasms 464 (1.67) 272 191 49.7 52
V. Germ cell tumors
1. Germinoma 204 (0.73) 148 56 17.4 16
2. Embryonal carcinoma 14 (0.05) 12 2 12.2 12.5
3. Yolk sac tumor 2 (0.01) 2 0 7 7
4. Choriocarcinoma 1 (0.00) 0 1 34 34
5. Teratoma 10 (0.04) 8 2 14.5 14
Mature 56 (0.20) 36 20 23.5 20.5
Immature 22 (0.08) 20 2 16 14.5
With malignant transformation 4 (0.01) 4 0 13.3 14
6. Mixed germ cell tumors 35 (0.13) 29 6 16.6 14
VI. Tumors of the sellar region
Craniopharyngioma 1144 (4.11) 665 477 32.1 33
Granular cell tumor 7 (0.03) 2 5 49 52
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Table 1 Histological features of 27802 cases from 1990 to 2009 (Continued)
Pituicytoma 1 (0.00) 1 0 45 45
Spindle cell oncocytoma of the adenohypophysis 1 (0.00) 1 0 24 24
VII. Metastatic tumors 1431 (5.15) 890 536 53.9 55
Total 27802 13945 13774
N = Number; M =Male; F = Female;
Ma =Median age at diagnosis; ma =Mean age at diagnosis;
PNET = Primitive neuroectodermal tumor;
Grade I meningothelial cells tumors =Meningiothelial; Fibrous, fibroblastic; Transitional, mixed; Psammomatous; Angiomatous; Microcystic; Secretory; Lymphop
lasmacyte-rich; Metaplastic.
Other mesenchymal tumors = Lipoma; Angiolipoma; Hibernoma; Liposarcoma; Solitary fibrous tumor; Fibrosarcoma; Malignant fibrous histiocytoma; Leiomyoma;
Leiomyosarcoma; Rhabdomyoma; Rhabdomyosarcoma; Chondroma; Chondrosarcoma; Osteoma; Osteosarcoma; Osteochondroma; Hemangioma; Angiosarcoma;
Kaposi sarcoma; Ewing sarcoma-PNET.
MPNST =Malignant peripheral nerve sheath tumor.
Table 2 Distributions of CNS tumors and top 4 subtypes
among children and teenagers (age 0-19)
Tumor N M F %
Tumors of neuroepithelial tissue 1791 1086 700 61.3
Astrocytoma 853 489 361 29.2
Medulloblastoma 383 254 128 13.1
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The cases in this report were collected from patients who
were diagnosed with CNS tumors and who were surgically
treated or received biopsies between 1950 and 2009. Due to
the loss of the original pathological sections, the cases from
1950 to 1989 could not be reassessed directly. In those
cases, crude classifications were performed according to
the previous pathological diagnoses that were used and
adopted by neurosurgeons and neuropathologists at the
time. However, our cases from 1990 to 2009 were
reassessed by neuropathologists from the Neuropathology
Department of Huashan Hospital according to the stan-
dards from the 2007 World Health Organization (WHO)
classification [3].
All the CNS tumors were divided into seven categories:
tumors of neuroepithelial tissue; tumors of the cranial and
paraspinal nerves; tumors of the meninges; lymphomas
and hematopoietic neoplasms; germ cell tumors; tumors
of the sellar region; and metastatic tumors. Some differ-
ences exist between the WHO 2007 and WHO 2000 clas-
sifications; for example, gliomatosis cerebri was newly
included in astrocytic tumors, and pilomyxoid astrocy-
toma was added as a new subtype in pilocytic astrocytoma.
Consequently, we reassessed all the pilocytic astrocytoma
cases to separate the cases of pilomyxoid astrocytoma
from the old histological diagnoses. Extraventricular
neurocytoma, papillary glioneuronal tumor, and rosette-Figure 1 Distribution of CNS tumors by age and sex from 1990
to 2009.forming glioneuronal tumor of the fourth ventricle were
added to a neuronal and mixed neuronal-glial tumors sub-
type. Angiocentric glioma was grouped with other neuro-
epithelial tumors. For choroid plexus, atypical choroid
plexus papilloma was inserted between choroid plexus
papilloma and choroid plexus carcinoma [4].
The WHO classification offers a crude histological grad-
ing system, in which each CNS tumor is classified as grade
I-IV according to its degree of malignancy. This system
can provide an estimate for the prognosis of a patient. In
this study, age, sex, and the tumor histological type and
grade were systematically recorded. In the detailed classi-
fied cases (1990-2009), the gender data were lost for 83 of
the patients, and the age data were lost for 180 of the pa-
tients, representing 0.30% and 0.65% of the total, respect-
ively. Consequently, we excluded the lost gender or age
cases in the statistics of the sample. All the data analyses
were performed using SPSS (Statistical Package for the So-
cial Sciences) software.Ependymal tumours 180 113 67 6.2
Tumors of the sellar region 378 231 157 12.9
Craniopharyngioma 358 224 134 12.3
Tumors of the meninges 326 204 120 11.2
Germ cell tumors 237 182 54 8.1
Tumors of cranial and paraspinal nerves 163 94 69 5.6
Lympnomas and hematopoietic neoplasms 21 16 5 0.7
Metastatic tumors 6 3 3 0.2
Total 2922 1816 1108 100
N = Number; M =Male; F = Female.
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General features
From 1950 to 1989, 6338 cases could be grouped according
to their CNS tumors based on our crude classification.
Among these cases, 3530 were male, 2734 were female, and
935 were children and teenagers (age 0-19). Further details
are provided in Additional files 1 and 2.
From 1990 to 2009, 27,802 out of 43,595 cases with brain
disease could be grouped into CNS tumors according to
the 2007 WHO classification system. The other diseases in-
cluded pituitary adenoma for 7843 cases, cavernous malfor-
mation for 1247 cases, arteriovenous malformation for 848
cases, and other CNS diseases for 5854 cases (epidermoid
cysts, parasites, abscesses, and others). The proportion of
CNS tumors was 63.8%. Among these cases, 13945 were
males, 13774 were females, and 2903 were children and
teenagers (age 0-19). The distribution of the CNS tumors
by histological subtypes is shown in Table 1. Of the malig-
nant tumors, glioblastoma was the most common, with a
proportion of 29.5%. Metastatic tumor was the next
common and represented 19.4% of the total. These tumor
types were followed by anaplastic astrocytomas, anaplastic
oligodendromas, and others. The details are presented in
Table 1. A few rare CNS tumors were encountered in this
series, including new entities in the 2007 WHO classifica-
tion, such as anaplastic hemangiopericytoma (8 cases), pap-
illary tumors of the pineal region (2 cases), atypical choroid
plexus papillomas (2 cases), rosette-forming glioneuronal
tumor of the fourth ventricle (4 cases), and papillary
glioneuronal tumors (13 cases).Histological types by age and sex
Gender differences in morbidity were common in many of
the subtypes. From 1962 to 1989, all the CNS tumor sub-
types (except tumors of the meninges) occurred more fre-
quently in males (Additional file 1). Additionally, from 1990
to 2009, neuroepithelial tumors (the most common cat-
egory) were observed more frequently in male patients,
with a ratio of 1.47 according to this survey. Tumors of the
meninges exhibited a female/male ratio that exceeded 1.7Figure 2 Distribution of malignant tumors (WHO III-IV) by age
and sex from 1990 to 2009.according to our data (Table 1), whereas males were more
susceptible to germ cell tumors, with a ratio of 2.91.
The tumor distribution by age is another impressive as-
pect of brain tumor epidemiology. The histogram presented
in Figure 1 shows a peak proportion within the age range
from 30 to 60 in males, whereas the female patients seemed
to peak at an older age relative to the males. There was an-
other proportional peak from 10 to 19 years of age in the
male patients, and malignant tumors tended to occur more
frequently at that age. In adults, the top three subtypes
included tumors of the meningothelial cells (33.6%),
schwannoma (14.2%), and astrocytic tumors (11.4%). For
children and teenagers (age 0-19), astrocytomas were the
most common CNS tumors (29.2%), followed by medullo-
blastoma (13.1%) and craniopharyngioma (12.3%) (Table 2).
For the WHO III-IV grade tumors, two incidence
peaks were identified in both male and female patients,
with malignant tumors occurring more often in males at
each age group (Figure 2). The spectra of the malignant
tumors were different in the pediatric and adult groups
(Figure 3). For the adults, glioblastoma, metastatic
tumor, and anaplastic astrocytoma occupied the top
three places. However, for the pediatric cases (age 0-19),
the top three malignant tumors included medulloblas-
toma, germ cell tumors, and glioblastoma.
Time trends over the 60-year period
Over the past six decades, the number of patients has
grown tremendously. In contrast to 72 cases in 1962, there
were 3275 cases in 2009 (Additional file 3 & Figure 4), and
the growth rate had reached 106% to 139% in the three
most recent years. This trend was primarily the result of a
continuous enlargement of the hospital and the neurosurgi-
cal department, with other possible reasons that will be
discussed below. Gender differences were also noticeable.
From 1962 to 2006, male patients seemed to be the suscep-
tible population of CNS tumors, whereas over the last three
years, the situation reversed. The female/male ratios wereFigure 3 Some malignant tumors in children and elders from
1990 to 2009. GBM = Glioblastoma; MT = Metastatic Tumor;
MBM =Medulloblastoma; AA = Anaplastic astrocytoma; LYM =
Lymphoma; GER = Germinoma; AO = Anaplastic oligodendrocytoma;
AE = Anaplastic ependymoma; PNET = Primitive neuroectodermal
tumor; GSM = Gliosarcoma.
Figure 4 Time trends from 1990 to 2009 by sex.
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ing trend.
Although the incidence rates of all the CNS tumors in-
creased rapidly, certain subtypes of these tumors exhibited
remarkable increases (Figure 5). Lymphomas and hema-
topoietic neoplasms were 14.6-fold more common during
2005-2009 than during 1990-1994, whereas the incidence
of all CNS tumors increased only 4.9-fold. The second
highest increase in incidence was found for germ cell tu-
mors (7-fold), followed by meningiomas (6-fold). The inci-
dence of grade III-IV tumors increased much more rapidly
than that of grade I-II tumors and the average incidence
rate (Figure 6). The mean increase in neuroepithelial tu-
mors was equal to the average increase, but diverse
incidence rates existed among the subtypes. Oligoden-
drogliomas and oligoastrocytomas increased respectively
1.7 and 2.3 times faster than average (Figure 7). However,
the distribution of neuroepithelial tumors, the mostFigure 5 Growth rate of CNS tumors (90-94/05-09). I = Tumors of neuro
III = Tumors of meninges; IV = Lymphomas and hematopoietic neoplasms;
VII = Metastatic tumors.common category of CNS tumors, remained stable
throughout the 20-year period (Figure 8).
Discussion
A retrospective epidemiological review of brain tumors is
particularly important for future research because it can
demonstrate the changes in the tumor spectrum of a popu-
lation, reveal possible risk factors, and indicating potential
therapy methods. China is the most populous country in
the world, but it has not yet established a national incidence
rate for CNS tumors. Over the past 20 years, acknowledged
improvements have occurred in the economy and medical
services in China, with concurrent environmental and life-
style changes. Therefore, the epidemiological characteristics
of China can be helpful for a worldwide study and may help
predict possible future changes in undeveloped areas as
they undergo development. Finally, because of the differ-
ences that are present in each classification edition, theepithelial tissue; II = Tumors of cranial and paraspinal nerves;
V = Germ cell tumors; VI = Tumors of the sellar region;
Figure 6 Growth Rate (05-09/90-94) of CNS tumors by
WHO grade.
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ledge of CNS tumors.
The distribution of CNS tumor categories found in this
study did not exactly replicate the rates observed in previ-
ously published worldwide reports. Despite the selection
bias inherent in this single-center study, tumors of neuro-
epithelial tissue and the meninges were the two most com-
mon categories; the proportions were 38.0% and 36.5%,
respectively. A nationwide database in France revealed that
the proportions of these two categories were 53.9% and
28.8%, respectively, from 2004-2008 [5], whereas another
population-based report from CBTRUS (Central Brain
Tumor Registry of the United States) recorded rates of
33.7% and 35.5%, respectively, from 2004-2007 [6]. The rea-
son for this great variation remains unknown and requires
further investigation.
The tumor spectra varied from adults to children and
teenagers as well as from males to females. According to
the CBTRUS data, glioblastoma (17.7%) and anaplastic as-
trocytoma (2.1%) were the most common malignant tu-
mors in adults. In this study population, metastatic tumor,
glioblastoma, and anaplastic astrocytoma a larger propor-
tion in adults, whereas medulloblastoma, germ cell tumors,
and glioblastoma were more common among children and
teenagers.Figure 7 Growth rate of neuroepithelial tumors. N&M= Neuronal and m
EMT = Embryonal tumors; ODT = Oligodendroglial tumors; OAT = Oligoastro
AT = Astrocytic tumors.Among the pediatric cases, brain and spinal tumors have
been shown to be the second most common cancers
(20.2%) in Shanghai, China, based on a previous regional
study [7]. High proportions of astrocytomas (29.2%) and
medulloblastomas (12.3%) were found in children and teen-
agers in our series, which seems to be in accordance with
reports from other locations, such as Taiwan (population-
based study), France (population-based study), India (sin-
gle-center study), and Brazil (single-center study) [8-11].
However, a population-based study in Japan reported a
lower proportion of medulloblastomas relative to germ cell
tumors and craniopharyngiomas [12], whereas in France
(8.6%) and India (5.2%), ependymal tumors were observed
at higher proportions relative to germ cell tumors [8,9]. De-
tails are provided in Table 3. During the past 20 years, chil-
dren under the age of 4 were not permitted admission to
our center; therefore, the spectrum of pediatric CNS tu-
mors in our series might be distorted. The epidemiological
variability in the observed histopathology worldwide indi-
cates that the origin of these tumors might be closely re-
lated to racial and environmental factors.
Overall, a larger proportion of males had malignant CNS
tumors across all the age groups in this limited population.
Data from CBTRUS also revealed a male/female incidence
ratio of 1.38 during 2003-2007. For the neuroepithelial tu-
mors, the ratio (male/female) was 1.47 compared to 1.25
(2004-2007) from CBTRUS. Therefore, according to this
survey and to other regional studies [13-18], it can be as-
sumed that males tend to have a higher incidence of CNS
tumors. Because of the high incidence of neuroepithelial tu-
mors in men, gender difference could be a starting research
point that may lead to some valuable findings with respect
to tumor origins and chemotherapy. Gender difference
found for meninges tumors in our survey was also striking,
although we found a ratio (female/male) of only 1.7 com-
pared to the 2.68 ratio based on the CBTRUS data (2004-
2007). However, due to the widespread use of advanced
diagnostic technologies in China, we predict that this ratio
will increase in the near future.
For children and teenagers, the male/female ratio for
CNS tumors was 1.66 in the selected cases. Other studies
around the world have reported similar ratios: 1.1 in France
(population-based study), 1.31 in Japan (population-basedixed neuronal-glial tumors; CPT = Choroid plexus tumors;
cytic tumors; EPT = Ependymal tumors; TPR = Tumors of pineal region;
Figure 8 Distribution of neuroepithelial tumors by time.
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From our data, males accounted for 74.4% of the germ cell
tumors in the pediatric cases, a percentage that was similar
to the 69.6% reported by CBTRUS and to those reported
by other studies from various regions [8-12], indicating that
intrinsic factors also play important roles in oncogenesis.
Several studies have also revealed an increasing trend in
the incidence rate for CNS tumors in western countries. In
the United States, a population-based series showed that
the annual percent change (APC) was +1.1% from 1985-
1999 [19], whereas in France, an APC of +2.33% was ob-
served from 2000 to 2007 [13]. Clinically silent CNS tumors
have been identified in a larger proportion of the popula-
tion, particularly among the elderly, because of improved
imaging techniques [17,20]. Furthermore, the increasing
trend was more prominent among certain CNS tumor sub-
types [17,21-23]. xThe increased incidences of gliomas and
meningiomas were suspected to have resulted from the
widespread use of cell phones since the mid-1990s, but no
causal association was confirmed [24,25]. A larger sample
size, a uniform method of classification, and a longer obser-
vation time are necessary before we can reach a definitive
conclusion.
In China, a fast-growing and developing country, increas-
ing tumor morbidity has been blamed as one of the top
three causes of death [1], just as in most western countries.
Because it was not a population-based study, the APC in
this series reached +11.22%. In part, this increase could be
the result of the increase in hospital size, with the increasedTable 3 Proportions of top CNS tumor subtypes among childr
Astrocytoma
Country Author Period Age(yrs)
China 1990-2009 0-19 29.2%
Taipei Wong et al. [11] 1975-2004 0-18 36.9%
Japan Makino et al. [12] 1989-2008 0-15 38.6%
India Asirvatham et al. [8] 1990-2004 0-18 49.7%
France Bauchet et al. [9] 2004-2006 0-19 32.9%
Brazil Pinho et al. [10] 1989-2009 0-21 37.7%
US CBTRUS [6] 2004-2007 0-19 33.1%number of cases due to more sickrooms and operating
rooms, improved neurosurgical techniques making more
cases operable and treatable, and economic developments
that result in more affordable therapy for most patients.
Another key reason might be associated with an increased
detection rate of CNS tumors after the widespread use of
CT and MRI in both rural and urban areas in China, which
reinforced the referral bias. In the early 1980s, the first CT
machine was imported into Huashan hospital; this was also
the first CT machine in China. In the late 1980s, the first
MRI followed. Those machines contributed greatly to the
diagnosis of CNS tumors, and from Additional file 3, we in-
deed observe a continuous increase in the number of cases
during that period. Moreover, because the textile industry
was booming in a developing China during the 1980s,
women constituted the majority of textile workers. There-
fore, occupation-related risk factors were simultaneously
raised, and a case–cohort study showed a higher brain
tumor incidence in female textile workers during that
period in Shanghai [26]. The agreement with this data
series suggests that the large and detailed database from
our sample is very valuable because it reveals how quickly
the CNS tumor spectrum changed in China with respect to
the affected population characteristics.
The diverse growth rates of the CNS tumor subtypes are
also very worthy of consideration. The fastest growing cat-
egories of tumors in this study included lymphomas, germ
cell tumors, and tumors of the meninges. Lymphoma has
been ranked as one of the top ten malignant tumors in thisen and teenagers in different regions




13.1% 12.3% 8.1% 6.2%
15.8% 9.8 12.7% 6.8%
13.1% 13.7 14.4% 5.2%
12.0% 10.3% 3.0% 5.2%
13.1% 5.4% 3.6% 8.6%
16.3% 12.5% 7.0% 8.1%
12.0% 3.6% 4.8% 6.7%
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malignant tumors in China [27]. Despite the inherent
biases, certain chemical pollutants should be carefully con-
sidered [28,29]. Germ cell tumors are also thought to be
closely related to environmental factors. They exhibit a con-
siderable geographical variation in incidence, representing
3-15% of all primary pediatric intracranial neoplasms [30].
Reports from Japan revealed a step-up increase in the inci-
dence from 1980 to 1993 and indicated that winter-born
children were more susceptible [31,32]. For the tumors of
the meninges, increasing trends were observed around the
world [13,17,19,21-23,31], and improvements in the diag-
nostic technologies are still considered to be the major
causal factor. Worldwide studies have also demonstrated an
apparently increased incidence of metastatic tumors [33],
but this increase was less prominent in our series. The dif-
ference might be an artifact of this investigation, as this is a
pathological-based review; thus, brain metastasis could have
been detected earlier and have been well controlled by ra-
diosurgery without pathological proof. According to our
study, most of the fastest increasing subtypes were also ma-
lignant, which underscored our need to be more cautious.
Therefore, we need more large-scale population-based
studies to identify the real risk factors.
As a single-center retrospective series, the data in this
study could not represent the national epidemiology of
CNS tumors. The pathological diagnoses included in this
study were only from patients under surgery or biopsy. Fur-
thermore, surgical treatments were not commonly used in
some advanced malignant tumors. Therefore, the distribu-
tion of some of the tumor subtypes might be artificially
high or low due to the unclear denominator. In brief, vari-
ous biases were unavoidable in this study, which means that
the conclusions should be evaluated with caution.Conclusions
This study retrospectively analyzed a large-scale and long-
term pathological database from a single neurological center.
Although it was not a large population study, and a selection
bias inevitably existed, the rapidity of the observed changes
in the CNS tumor spectrum with respect to the affected
population characteristics in China could model similar
changes that will occur in other developing countries.
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